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The current study explores the anticoagulant, fibrinogenolytic and anti-platelet aggregation activities of
Lablab purpureus (L.) Sweet seed radicle extract (LPRE). It is firstly reported that LPRE has protein at a
concentration of 1.5 mg/ml and further evaluated for protein in gel electrophoresis. The proteolytic
activity of LPRE was evaluated using casein and gelatin as substrate. LPRE showed a specific activity of
0.35 U. LPRE increased the plasma clotting time significantly showing its anticoagulant property. LPRE
hydrolyzed the Aα, Bβ and γ chains of fibrinogen. Furthermore, LPRE significantly inhibited the platelet
aggregation induced by agonist adenosine diphosphate (ADP). 
Introduction
According  to  World  Health  Organization  (WHO)
cardiovascular  disease  (CVDs)  remains  a  prominent
cause  of  mortality  from  myocardial  infarctions,
strokes from usual blood clots (1, 2). About 31% of the
global deaths are from CVDs, and about 85% of them
are from stroke and heart attack.  Overactivity of the
coagulation cascade (hypercoagulation) increases the
risk  of  thrombosis  formation  leading  to
thromboembolisms which in turn lead to ischemia by
blocking blood flow and damaging the organs (3). 
Blood  coagulation  has  an  intricate,  highly
controlled network of reactions involving coagulation
factors  which  gets  activated  sequentially  forming  a
blood clot. Unregulated blood clot formation leads to
formation of thrombus (4). Thrombosis could lead to
occlusion of blood vessels and should be treated with
anti-coagulant drugs (5).
Thrombosis is treated with anticoagulants such as
unfractionated  heparin  (UFH),  coumarins,  low
molecular  weight  heparin  (LMWH)  and
pentasaccahride  fondaparinux  (6).  Even  though  the
anticoagulants  are  efficient,  the  problem  in  their
administration  and  the  deleterious  life-threatening
side effects such as bleeding complications limit their
usage (7). Since the anticoagulant drugs are expensive
and  have  serious  side  effects,  there  is  a  need  to
explore alternative anticoagulants with more efficacy
and less side effects. 
Medicinal plants/plant extracts have been used in
traditional  Ayurvedic  medicinal  practitioners  to
prevent  and/or  treat  various  ailments  (8).  There are
several  medicinal  plants  reported  to  be  having
anticoagulant property and can serve as an alternative
for  current  anticoagulant  agents  (9).  Several  studies
have  reported  that  dietary  anticoagulants/
phytoconstituents  could  reduce  the  risks  of
thromboembolism (10, 11).
The  Lablab  purpureus  (L.)  Sweet belongs  to  the
family Fabaceae. Different parts of the plant is used as
anti-inflammatory,  aphrodisiac,  antispasmodic,
antidiabetic,  febrifuge,  bilious,  stomachic  and
phlegmatic  disorders  (12,  13).  In addition,  the  plant
decoction has  been used in alcoholic  intoxication to
treat cholera, diarrhoea, gonorrhoea, leucorrhoea and
in globefish poisoning. The seed pods juice was used
to treat the digestive problems, expel worms and to
treat inflamed throat and ears. The flowers are used to
treat  uterus  inflammation  and  increase  menstrual
flow (14, 15).
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In  view  of  finding  a  natural  dietary
anticoagulant, this study we have investigated the in
vitro anticoagulant, fibrinogenolytic and anti-platelet
aggregation activities of  Lablab purpureus (L.)  Sweet
seed radicle extract (LPRE).
 
Materials and Methods
Sample  collection  and  aqueous  extract
preparation 
Lablab  purpureus  (L.)  Sweet seeds  (round  and
matured)  were  procured  from  merchandise  in
Tumkur district  (13.3379o N,  77.1173o E),  Karnataka
state,  India.  L.  purpureus  (L.)  Sweet plants  were
grown in Tumkur at temperature between 28-30 oC in
high organic  matter  soil.  The seeds were harvested
during September – December months. The plant was
identified  by  Prof.  Sharanappa,  Professor,
Department of Biosciences, Hemagangotri, University
of  Mysore,  Hassan.  A  herbarium  specimen  was
maintained in Department of Studies and Research in
Botany, Tumkur University, Tumkur (TUB-012). 
Seeds  (500  gm)  were  soaked in  distilled  water
(1l) for 48 hr. The soaked seeds were kept in a closed
container  for  48  hr at  37  oC  for  sprouting.  The
sprouted  seeds  were  collected.  Sprout  radicle  was
separated from cotyledon and dried in an incubator
at 40 oC with humidity upto 70% for 48 hr. The dried
sprout radicles were finely powdered using electrical
grinder and stored at ˉ20 oC freezer (humidity about
95%) until  further use. The radicle powder (10 gm)
was suspended in distilled water (100 ml) and kept on
magnetic stirrer for 24 hr at a speed of 400 rpm to
prepare  aqueous  extract.  Later  the  extract  was
centrifuged  at  10000  rpm (Remi  C-24BL centrifuge)
and supernatant was collected. The supernatant was
concentrated  and  named  as  Lablab  purpureus (L.)
Sweet seed radicle extract (LPRE). The LPRE stored at
ˉ20 ºC (humidity about 95%) freezer until further use.
Protease activity
Protease activity was analysed (16) using casein (2%
in  200  mM  Tris-hydrochloric  acid  (HCl)  buffer,  pH
8.0) as substrate. LPRE was incubated with 0.4 ml of
casein  at  37  oC  for  180  min.  Later,  the  reaction
terminated  by  adding  trichloroacetic  acid  and  the
sample  centrifuged  (3000  rpm  for  5  min).  After
centrifugation 1 ml of supernatant was collected and
sodium  carbonate  and  diluted  Folin-Ciocalteu
reagents were added and kept at  37  oC for 20 min.
The intensity of the colour developed was measured
using  Elico  CL63  colorimeter  at  660  nm.  Enzyme
activity  was  stated  as  the  enzyme  required  for  an
incremental  increase  of  absorbance  by  0.01  at  660
nm in 1 hr.
Electrophoresis
Sodium  dodecyl  sulphate  polyacrylamide  gel
electrophoresis  (SDS-PAGE)  was  carried  out
according  to  standard  procedure  (17).  LPRE  was
loaded onto 10% gel and electrophoresis was carried
out  for  2  hr at  90  Volts.  Gel  was stained  with
Coomassie brilliant blue R-250 (CBB) and visualized
using Gel.LUMINAX gel documentation system.
Zymography
Casein/gelatin  zymogram was  carried  out  (17).  The
10% gel incorporated with gelatin (0.2%) as substrate
used for zymogram assay.  LPRE was  incubated with
sample buffer and electrophoresis was done. SDS was
removed using Triton X-100 and gel was incubated in
buffer  (COMPOSITION)  overnight.  The  gel  was
stained with CBB.
Fibrinogenolytic activity
Fibrinogenolytic activity was carried out (18). Human
fibrinogen (50 µg) incubated for 2.5 h at 37  oC with
different  concentrations  of LPRE  in  sodium
phosphate buffer. After incubation reducing sample
buffer  was added and we analyzed the hydrolyzed
products in 12% SDS-PAGE.
Coagulation assays
Recalcification time (RT)
The  RT  was  determined  following  standard
procedure  (19). Citrated human plasma (100 µl) was
incubated with LPRE (3 - 18 μg) at 37 ºC for 15 min.
After incubation, 100 µl  of 25 mM CaCl2 was added
and  time  taken  for  visible  clot  formation  was
recorded. 
Prothrombin time (PT)
PT  was  determined  as  per  standard  procedure
(20).  100  μl  of  plasma  was  incubated  with
different  concentrations  of  LPRE  (6  -  36  μg)  at
37  ºC  for  15  min.  After  incubation,  0.2  ml  of
liquid  calcified  thromboplastin  (Uniplastin
reagent  from  Tulip  Diagnostics  Pvt.  Ltd.,  Goa)
was  added  and  time  taken  for  clot  formation
was recorded. 
Activated partial thromboplastin time (aPTT)
APTT kit was procured from Tulip Diagnostics Pvt. Lt.
Goa.  The assay  was performed as  described in  the
manufacturer’s protocol. Citrated human plasma (100
µl) was incubated with LPRE (6 - 30 μg) at 37 ºC for 5
min.  After  incubation  100  μl of  Liquicelin-E  was
added and kept  for 5  minutes.  100 μl of  CaCl2 was
added  and  time  for  visible  clot  formation  was
recorded. 
Platelet aggregation
Platelet  aggregation  was  analysed  in  Chrono-Log
Model  700-2D  aggregometer  (ChronoLog  Corp.,
USA). We collected blood from healthy volunteers.
Platelet-rich  plasma  (PRP)  was  obtained  by
centrifuging  human  blood  (1:9  v/v  in  3.2%
trisodium  citrate)  at  900  rpm  for  15  min;  the
resultant supernatant was PRP. The blood sample
was centrifuged at 3000 rpm for 20 min to obtain
Platelet Poor Plasma (PPP) as the supernatant. 250
μl  of  PRP  was  taken  in  siliconized  glass  cuvette
with  stir  bar  stirring  at  1200  rpm.   The  platelet
aggregation was initiated by adding ADP (10 μm).
Different  concentration  of  LPRE  incubated  with
PRP for 15 min and aggregation were initiated by
adding ADP. The aggregation was monitored for 6
minutes by change in turbidity with PRP and PPP
representing  0%  and  100%  transmittance
respectively.
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Protein estimation
Protein concentration was estimated (21) and BSA is
used as standard. 
Statistical analysis
Results were represented as mean  ± standard error.
One-way analysis of variance was used for statistical
significance of intergroup differences and the Tukey
test  was  used  for  comparison  of  means.  The
Statistical Package for Social Sciences (SPSS) version
15.0 (SPSS Inc., Chicago, IL, USA) was used to perform
all analysis.
Results and Discussion
The Lablab purpureus (L.)  Sweet seed radicle extract
(LPRE)  has  a  protein  concentration  of  1.5  mg/ml.
Analysis of LPRE by SDS-PAGE showed protein bands
distributed  majorly  in  medium  molecular  weight
region (Fig. 1). LPRE showed a proteolytic activity of
0.35 U.  In zymogram study (using casein and gelatin
as substrate) LPRE showed translucent activity bands,
confirming  protease  (Fig.  2).  Proteases  from  seeds
have  broad  specificity.  They  can  hydrolyse  casein,
gelatin and extracellular matrix (22, 23).   
Blood  coagulation  is  a  complex  physiological
process  that  drives  immediate  response  to  blood
vessel  injury.  Impairment  in  coagulation  process
leads  to  the  hyper-activation  of  the  coagulation
factors,  which  results  in  thrombotic  disorders  (4).
Thrombosis  results  in  formation  of  unusual  clot  in
the  arteries  and  veins  increasing
cerebrovascular/cardiovascular  complications  (6).
Currently available  antithrombotic  agents have life-
threatening  side  effects.  Anticoagulants  from  the
natural sources are preferable for curing thrombotic
disorders. Several anticoagulant agents from natural
sources  of  plant/seed  extracts  have  reported  and
these could be a better therapeutic candidate to treat
thrombosis. The seed extract of Momordica charantia,
Artocarpus  heterophyllus,  Pisum  sativum,
Macrotyloma  uniflorum and  Linum  usitatissimum
seeds found to show anticoagulant and anti-platelet
aggregation effects (22, 23, 25). 
LPRE showed significant  anticoagulant  activity.
Upon  incubation  with  plasma,  LPRE  increased  the
clotting time in RT from control  200 sec to 700 sec
with 18 µg (Fig. 3A), in PT from control 16 sec to 700
sec with 36 μg (Fig. 3B) and in APTT from control 36
sec to 665 sec with 30 μg  (Fig. 3C) concentration. In
RT calcium activates the common pathway of blood
coagulation.  Calcium  along  with  phospholipid  and
Fig.1. Electrophoresis.  LPRE (120  µg)  was  loaded on to  the 10%
SDS-PAGE  in  non-reducing  and  reduced  conditions.  Lane  M:
molecular weight markers, lane 1: LPRE (120 µg) in non-reducing
condition, lane 2: LPRE (120 µg ) in reducing condition.
A
B
Fig. 2. Zymogram assay. The LPRE was loaded onto SDS-PAGE co-
polymerized  with  gelatin  (A) or  casein  (B) for  the  detection  of
proteolytic  activity.  After  electrophoresis,  SDS  was  removed  by
using Triton X-100. Later incubated overnight in incubation buffer
and stained with CBBR-250.  Lane 1: Trypsin (5 µg) 2 and 3: LPRE
50 µg and 100 µg.
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factor V activates factor II.  PT was evaluated using
uniplastin  reagent  containing  ready  to  use  liquid
calcified  thromboplastin  reagent.  Thromplastin  in
presence of calcium activates the extrinsic pathway
of  human  blood  coagulation.  While  APTT  was
evaluated  using  liquicelin-E  reagent  containing
phospholipid  with  ellagic  acid  as  an  activator.
Cephaloplastin  activates  the  coagulation  factors  of
intrinsic  pathway  of  coagulation  mechanism in  the
presence  of  calcium.  This  suggests  that  LPRE
interfere  in  intrinsic,  extrinsic  and  in  common
pathway  of  coagulation  cascade.  The  protease(s)
present in the LPRE sample might be responsible for
the anticoagulant property exhibited (22).
We  evaluated  the  fibrinogenolytic  activity  for
LPRE.  The  LPRE  hydrolysed  all  the  chains  of
fibrinogen (Aα, Bβ and γ) at a concentration of 3 μg in
a  dose  dependent  manner  (Fig.  4).  Generally,
proteases  which  degrade  fibrinogen  from  its  C-
terminal  end  generate  truncated  fibrinopeptides
exhibiting  anti-coagulant  activity.  Similar
fibrinogenolytic  activity  has  been  reported  from
Tridax  procumbens,  Jatropha  curcas and  Plumeria
alba (23 - 25).
Platelets  are  anuclear  discoid-shaped  cells
originating  from  stem  cells  of  bone  marrow
megakaryocytes  which  play  an important  role  in
blood coagulation (26). The platelets  aggregate  to
form platelet plug at the site of injury, along with
fibrin  clot  to  form blood clot.  During  thrombotic
disorder,  platelets  also  contribute  for  the
formation  of  an  unusual  clot  in  blood  vessels.
LPRE  significantly  inhibited  the  ADP-induced
platelet  aggregation  to  an  extent  of  80%  at  the
concentration  of  100  μg  (Fig.  5A and  B).  The
factors that act as antiplatelet  aggregating agents
play  a key role in inhibiting unusual  blood clots.
Several  antiplatelet  agents  have  been  reported





Fig.  3.  Coagulation  studies.  A.  Recalcification  time. Different
concentration  of  LPRE  (3  -  18  μg)  was  incubated  with  human
plasma (100 μl) for 5 min. After incubation,  100 μl of CaCl2 was
added and time taken for visible clot formation was recorded.  B.
Activated  partial  thromboplastin  time  (aPTT).  Different
concentration of the LPRE (6 - 30 μg) was incubated with 100 µl of
plasma for 10 min and after incubation 100 µl of liquicelin-E was
added and again incubated for 5 min. To this mixture 100 µl  of
CaCl2 was  added and  time  taken  for  visible  clot  formation  was
recorded.  C. Prothrombin  time  (PT).  Different  concentration  of
LPRE (6 - 36 µg) was incubated with 100 µl of plasma for 10 min
and after incubation 200 µl of uniplastin was added, the clotting
time  was  recorded.  All  the  values  are  presented  as  mean  ±
standard error of the mean (n=5).
Fig.  4.  Fibrinogenolytic  activity.  Human fibrinogen  (50  µg)  was
incubated with LPRE (0.06 µg, 0.3 µg and 3 µg) at 37 o C for 2.5 h.
SDS-PAGE performed under reducing condition. Lane 1: fibrinogen
(50 µg), lane 2 - 4: fibrinogen incubated with 0.06 µg, 0.3 µg and 3
µg of LPRE respectively.
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Conclusion
The present study for the first time demonstrates that
Lablab  purpureus (L.)  Sweet  seed  radicle  extract
(LPRE) has  proteolytic  activity  associated  with
fibrinogenolytic activity which exhibit anticoagulant
and anti-platelet aggregation effect. The findings give
an  opportunity  for  isolation  of  bioactive  molecule
from LPRE with potent anticoagulant property which
can be further used in clinical applications.
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